Phase 1 Ocular Hypertension Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
Open Angle GlaucomaOcular Hypertension
AbbVie96 enrolled49 locationsNCT04499248
Recruiting
Phase 1
Pregabalin (PRG) ophthalmic solutions in patients diagnosed with Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Ocular Hypertension (OHT)
Tavo Biotherapeutics32 enrolled1 locationACTRN12625000766415
Recruiting
Phase 1
Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery
GlaucomaOcular Hypertension
EyeD Pharma18 enrolled1 locationNCT07036510
Recruiting
Phase 1
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Open Angle GlaucomaOcular Hypertension
Amneal Pharmaceuticals, LLC240 enrolled4 locationsNCT06267274
Recruiting
Phase 1
Phase I study of a Latanoprost Ocular Implant for treatment of Open Angle Glaucoma or Ocular Hypertension.
Open Angle GlaucomaOcular Hypertension
PolyActiva Pty Ltd6 enrolled1 locationACTRN12621001718831